[
  {
    "ts": "2026-02-04T13:31:00+00:00",
    "headline": "GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook",
    "summary": "GSK's Q4 earnings and sales top estimates as strong specialty medicine demand fuels growth and drives shares higher on an upbeat 2026 outlook.",
    "url": "https://finance.yahoo.com/news/gsks-q4-earnings-sales-beat-133100931.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "ed0ba2a1-c5cd-3f12-a860-2e47031c56c5",
      "content": {
        "id": "ed0ba2a1-c5cd-3f12-a860-2e47031c56c5",
        "contentType": "STORY",
        "title": "GSK's Q4 Earnings & Sales Beat Estimates, Stock Up on '26 Outlook",
        "description": "",
        "summary": "GSK's Q4 earnings and sales top estimates as strong specialty medicine demand fuels growth and drives shares higher on an upbeat 2026 outlook.",
        "pubDate": "2026-02-04T13:31:00Z",
        "displayTime": "2026-02-04T13:31:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/gsks-q4-earnings-sales-beat-133100931.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/gsks-q4-earnings-sales-beat-133100931.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "GSK"
            },
            {
              "symbol": "GLAXF"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T16:25:00+00:00",
    "headline": "Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?",
    "summary": "The company projects that its oncology sales will roughly double in the not-too-distant future.",
    "url": "https://www.fool.com/investing/2026/02/04/johnson-jnj-back-to-double-digit-growth-stock/",
    "source": "Motley Fool",
    "provider": "yfinance",
    "raw": {
      "id": "1a957d0d-7f3c-3471-8f02-c54513902006",
      "content": {
        "id": "1a957d0d-7f3c-3471-8f02-c54513902006",
        "contentType": "STORY",
        "title": "Johnson & Johnson's Getting Back to Double-Digit Growth. Has the Stock Become a Bargain Buy?",
        "description": "",
        "summary": "The company projects that its oncology sales will roughly double in the not-too-distant future.",
        "pubDate": "2026-02-04T16:25:00Z",
        "displayTime": "2026-02-04T16:25:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/motleyfool.com/44e49a7bf0d1a8ac61c1251629389e72",
          "originalWidth": 1400,
          "originalHeight": 933,
          "caption": "A person receiving a vaccine from a nurse.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/GlDKTurDeJHgldu4352bbw--~B/aD05MzM7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/motleyfool.com/44e49a7bf0d1a8ac61c1251629389e72.cf.webp",
              "width": 1400,
              "height": 933,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/oKtMXyXtKJoJ2NWD8yuTLg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/motleyfool.com/44e49a7bf0d1a8ac61c1251629389e72.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Motley Fool",
          "url": "http://www.fool.com/"
        },
        "canonicalUrl": {
          "url": "https://www.fool.com/investing/2026/02/04/johnson-jnj-back-to-double-digit-growth-stock/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnsons-getting-back-double-162500386.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T16:20:37+00:00",
    "headline": "Johnson & Johnson Deepens Oncology And MedTech Footprint With New Approvals",
    "summary": "Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination therapy for newly diagnosed multiple myeloma patients who are ineligible for stem cell transplant. Johnson & Johnson MedTech launched NuVision Nav, described as the world's first fully integrated 4D intracardiac imaging catheter, alongside updates to its pulsed field ablation technology. Johnson & Johnson, trading at $233.1, is adding fresh catalysts to its oncology and MedTech franchises with these...",
    "url": "https://finance.yahoo.com/news/johnson-johnson-deepens-oncology-medtech-162037751.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "ec0f3686-970d-3ba7-b0ab-5d31dd1c6bc8",
      "content": {
        "id": "ec0f3686-970d-3ba7-b0ab-5d31dd1c6bc8",
        "contentType": "STORY",
        "title": "Johnson & Johnson Deepens Oncology And MedTech Footprint With New Approvals",
        "description": "",
        "summary": "Johnson & Johnson (NYSE:JNJ) received FDA approval for DARZALEX FASPRO in combination therapy for newly diagnosed multiple myeloma patients who are ineligible for stem cell transplant. Johnson & Johnson MedTech launched NuVision Nav, described as the world's first fully integrated 4D intracardiac imaging catheter, alongside updates to its pulsed field ablation technology. Johnson & Johnson, trading at $233.1, is adding fresh catalysts to its oncology and MedTech franchises with these...",
        "pubDate": "2026-02-04T16:20:37Z",
        "displayTime": "2026-02-04T16:20:37Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/VmOStVnJjLnU3xikg4stLA--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/trESudVvS0UypUeXuQ_Yww--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/4e8319e0e61499a110aef17faa48c1a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-deepens-oncology-medtech-162037751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-deepens-oncology-medtech-162037751.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T15:45:00+00:00",
    "headline": "Biopharmaceutical Industry Set for Unprecedented Growth in 2025: Key Trends and Contributions by Global Leaders",
    "summary": "According to Precedence Research, the global biopharmaceutical industry continues to experience robust growth in 2025, with the top 20 companies leading the charge in various therapeutic areas such as oncology, immunology, and vaccines. These industry giants are not only shaping healthcare innovations but also experiencing remarkable revenue growth. The list includes key players such as Merck & Co., Pfizer, and Johnson & Johnson, with each company contributing to the evolution of the biopharma l",
    "url": "https://finance.yahoo.com/news/biopharmaceutical-industry-set-unprecedented-growth-154500153.html",
    "source": "GlobeNewswire",
    "provider": "yfinance",
    "raw": {
      "id": "943eade1-2ab9-3255-bdc6-15097c59e631",
      "content": {
        "id": "943eade1-2ab9-3255-bdc6-15097c59e631",
        "contentType": "STORY",
        "title": "Biopharmaceutical Industry Set for Unprecedented Growth in 2025: Key Trends and Contributions by Global Leaders",
        "description": "",
        "summary": "According to Precedence Research, the global biopharmaceutical industry continues to experience robust growth in 2025, with the top 20 companies leading the charge in various therapeutic areas such as oncology, immunology, and vaccines. These industry giants are not only shaping healthcare innovations but also experiencing remarkable revenue growth. The list includes key players such as Merck & Co., Pfizer, and Johnson & Johnson, with each company contributing to the evolution of the biopharma l",
        "pubDate": "2026-02-04T15:45:00Z",
        "displayTime": "2026-02-04T15:45:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7",
          "originalWidth": 1667,
          "originalHeight": 1667,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/2XVm_GDF06LCL8xJEgs9kg--~B/aD0xNjY3O3c9MTY2NzthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7.cf.webp",
              "width": 1667,
              "height": 1667,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/ciHBcKYhN1HkkZYm0oIo1A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/47160fa420d06f24420d9a27698245a7.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "GlobeNewswire",
          "url": "https://www.globenewswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/biopharmaceutical-industry-set-unprecedented-growth-154500153.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/biopharmaceutical-industry-set-unprecedented-growth-154500153.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "MRK"
            },
            {
              "symbol": "PFE"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "RHHBF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T15:55:14+00:00",
    "headline": "The John Bogle Method for Building a Dividend Portfolio Under $10,000",
    "summary": "John Bogle, the legendary Vanguard Group founder and index fund pioneer, left an enduring legacy of knowledge and inspiration. He was wealthy, of course, but you can apply Bogle’s dividend investment principles with $10,000 or less. Plenty of today’s investors are enamored with high-yield stocks, but Bogle didn’t over-focus on the biggest dividends. Instead, he ... The John Bogle Method for Building a Dividend Portfolio Under $10,000",
    "url": "https://247wallst.com/investing/2026/02/04/the-john-bogle-method-for-building-a-dividend-portfolio-under-10000/",
    "source": "24/7 Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "82b4b464-2f23-391e-b31c-033afc0e2329",
      "content": {
        "id": "82b4b464-2f23-391e-b31c-033afc0e2329",
        "contentType": "STORY",
        "title": "The John Bogle Method for Building a Dividend Portfolio Under $10,000",
        "description": "",
        "summary": "John Bogle, the legendary Vanguard Group founder and index fund pioneer, left an enduring legacy of knowledge and inspiration. He was wealthy, of course, but you can apply Bogle’s dividend investment principles with $10,000 or less. Plenty of today’s investors are enamored with high-yield stocks, but Bogle didn’t over-focus on the biggest dividends. Instead, he ... The John Bogle Method for Building a Dividend Portfolio Under $10,000",
        "pubDate": "2026-02-04T15:55:14Z",
        "displayTime": "2026-02-04T15:55:14Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/24_7_wall_st__718/e944e5af34f277979068d26f613f8aad",
          "originalWidth": 1366,
          "originalHeight": 768,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dfwQMn5_OjPdhAUqk.Fa_w--~B/aD03Njg7dz0xMzY2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/24_7_wall_st__718/e944e5af34f277979068d26f613f8aad.cf.webp",
              "width": 1366,
              "height": 768,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TLnn8U5jDxSKDEK7eVd5ag--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/24_7_wall_st__718/e944e5af34f277979068d26f613f8aad.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "24/7 Wall St.",
          "url": "https://247wallst.com/"
        },
        "canonicalUrl": {
          "url": "https://247wallst.com/investing/2026/02/04/the-john-bogle-method-for-building-a-dividend-portfolio-under-10000/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/john-bogle-method-building-dividend-155514887.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "XOM"
            },
            {
              "symbol": "AXP"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T17:28:00+00:00",
    "headline": "AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View",
    "summary": "ABBV beats Q4 earnings and revenue estimates, but shares slip as Rinvoq and oncology sales miss expectations despite strong 2026 EPS guidance.",
    "url": "https://finance.yahoo.com/news/abbvie-beats-q4-earnings-stock-172800060.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "407f6098-375e-3af9-a494-c3def4bae98b",
      "content": {
        "id": "407f6098-375e-3af9-a494-c3def4bae98b",
        "contentType": "STORY",
        "title": "AbbVie Beats on Q4 Earnings, Stock Down Despite Upbeat '26 View",
        "description": "",
        "summary": "ABBV beats Q4 earnings and revenue estimates, but shares slip as Rinvoq and oncology sales miss expectations despite strong 2026 EPS guidance.",
        "pubDate": "2026-02-04T17:28:00Z",
        "displayTime": "2026-02-04T17:28:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-beats-q4-earnings-stock-172800060.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-beats-q4-earnings-stock-172800060.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T18:45:03+00:00",
    "headline": "Dozens of Stocks Hitting 52-Week Highs",
    "summary": "A significant number of stocks in the S&P 500 reached new 52-week intraday highs during Wednesday trading, signaling a broadening of market participation despite a retreat in the technology sector.    While a selloff in tech shares weighed on major indexes, 82 stocks in the S&P 500 hit one-year peaks by midday, according to Dow Jones Market Data.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-04-2026/card/dozens-of-stocks-hitting-52-week-highs-RVYVXvgA2CXmT9yj7x9u?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b6e7c836-9b61-3160-9c2b-5aed8a0c5bc3",
      "content": {
        "id": "b6e7c836-9b61-3160-9c2b-5aed8a0c5bc3",
        "contentType": "STORY",
        "title": "Dozens of Stocks Hitting 52-Week Highs",
        "description": "",
        "summary": "A significant number of stocks in the S&P 500 reached new 52-week intraday highs during Wednesday trading, signaling a broadening of market participation despite a retreat in the technology sector.    While a selloff in tech shares weighed on major indexes, 82 stocks in the S&P 500 hit one-year peaks by midday, according to Dow Jones Market Data.",
        "pubDate": "2026-02-04T18:45:03Z",
        "displayTime": "2026-02-04T18:45:03Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b6e7c836-9b61-3160-9c2b-5aed8a0c5bc3/dozens-of-stocks-hitting.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-04-2026/card/dozens-of-stocks-hitting-52-week-highs-RVYVXvgA2CXmT9yj7x9u?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "CAT"
            },
            {
              "symbol": "RTX"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-04T21:47:27+00:00",
    "headline": "Nearly 20% of S&P 500 Stocks Hit 52-Week Highs Today",
    "summary": "Nearly 100 stocks in the S&P 500 reached new 52-week intraday highs during Wednesday trading, signaling a broadening of market participation despite a retreat in the technology sector.    While a selloff in tech shares weighed on the market, 92 stocks in the S&P 500 hit one-year peaks, according to Dow Jones Market Data.",
    "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-04-2026/card/dozens-of-stocks-hitting-52-week-highs-RVYVXvgA2CXmT9yj7x9u?siteid=yhoof2&yptr=yahoo",
    "source": "The Wall Street Journal",
    "provider": "yfinance",
    "raw": {
      "id": "b6e7c836-9b61-3160-9c2b-5aed8a0c5bc3",
      "content": {
        "id": "b6e7c836-9b61-3160-9c2b-5aed8a0c5bc3",
        "contentType": "STORY",
        "title": "Nearly 20% of S&P 500 Stocks Hit 52-Week Highs Today",
        "description": "",
        "summary": "Nearly 100 stocks in the S&P 500 reached new 52-week intraday highs during Wednesday trading, signaling a broadening of market participation despite a retreat in the technology sector.    While a selloff in tech shares weighed on the market, 92 stocks in the S&P 500 hit one-year peaks, according to Dow Jones Market Data.",
        "pubDate": "2026-02-04T21:47:27Z",
        "displayTime": "2026-02-04T21:47:27Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/b6e7c836-9b61-3160-9c2b-5aed8a0c5bc3/nearly-20-of-s-p-500-stocks.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
          "originalWidth": 1200,
          "originalHeight": 630,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AC.ajdS9OghfMNW3mzlvpg--~B/aD02MzA7dz0xMjAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 1200,
              "height": 630,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/J5JxVR9DmLuomtxdXBS7Uw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "The Wall Street Journal",
          "url": "http://www.wsj.com/"
        },
        "canonicalUrl": {
          "url": "https://www.wsj.com/livecoverage/stock-market-today-dow-sp-500-nasdaq-02-04-2026/card/dozens-of-stocks-hitting-52-week-highs-RVYVXvgA2CXmT9yj7x9u?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "^GSPC"
            },
            {
              "symbol": "CAT"
            },
            {
              "symbol": "RTX"
            },
            {
              "symbol": "WMT"
            },
            {
              "symbol": "XOM"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]